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The American College for Advancement in Medicine’s
(ACAM) 64th International Educational Symposium on
Complementary, Alternative and Integrative Medicine
(CAIM) was held on November 9–13, 2005 at the Anaheim
Hilton Hotel in Anaheim, California. ACAM’s Fall 2005 con-
ference, ‘Scientific Integrative Medicine: Advancing Health
Horizons’, offered a total of 70.5 AMA CME credits and
brought together an international cadre of approximately 600
physicians, scientists and medical students/residents (from
nine countries) for a fascinating educational program on the
scientific and clinical evidence supporting the practice of a
wide range of CAIM therapies.
Conference keynote presentations addressed a diverse
breadth of common medical conditions and provided scientific
substantiation for many of the most effective treatments used
by physicians who have successfully incorporated CAIM into
their practice of medicine. Presenters highlighted strategies
for successfully using CAIM to address conditions such as
hypothyroidism, hypertension, endothelial dysfunction,
degenerative disc disease, osteoporosis, infectious diseases
(bacterial and viral) and the autistic spectrum disorders.
Keynote lectures also focused upon the effects of nutrient–
gene interactions and the vast spectrum of potential therapeutic
interventions using nutrients to address and to compensate for
common single nucleotide polymorphisms (SNPs). Presenters
also emphasized the importance of epigenetic gene modifi-
cation and they elucidated the mechanisms by which food,
nutrients and environmental toxins, such as heavy metals, can
modify gene expressions.
In a featured lunchtime awards ceremony, actress and author
Suzanne Somers became the first recipient of ACAM’s Legacy
Award for her dedication to making the public more aware of
the use of bio-identical hormones in the treatment of the peri-
and post-menopausal symptoms. Her best selling book, The
Sexy Years, featured interviews with many forward-thinking
clinicians and noted integrative physicians who have help-
ed bring bio-identical hormone replacement therapy into
the forefront of the American public. During her moving
presentation, Ms Somers emphasized the importance of
physicians educating their patients with regard to treatment
options that use bio-identical hormone replacement therapy.
She commended medical organizations such as ACAM for
their open-minded approach and for the training they impart to
thousands of physicians and medical students. Ms Somers also
highlighted her own innovative approaches and experience in
her battle against breast cancer. The awards ceremony
received rave reviews and Ms Somers received a standing
ovation after her presentation. Dr Allan Magaziner, ACAM’s
outgoing president, proudly presented Ms Somers with
ACAM’s first Citizen’s Legacy Award. ACAM’s Citizens
Legacy Award was established to recognize the outstanding
contributions of non-physicians toward bringing greater public
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therapies.
ACAM’s incoming president, Kenneth Bock, MD, observed
that the fall conference provided ‘solid and scientifically
based information supporting the field of integrative medicine
and that the therapies, discussed by the presenters, were readily
applicable to most physicians’ practice of medicine’. Dr Bock
assumed his leadership role as ACAM’s president follow-
ing the conference. During the conference, he emphasized
ACAM’s intention of ‘building bridges with other CAIM
organizations, as well as with more academic and conventional
medical organizations.’
A complete list of the keynote conference presentations can
be found following this article.
ACAM’s Fall 2005 meeting also offered four in-depth 2-day
pre-conference workshops along with a 1-day workshop on
Scientific Writing. Two-day workshop themes included
Prolotherapy, Hyperbaric Medicine, Nutrition and Metabol-
ism, and Chelation and Heavy Metal Toxicity.
ACAM’s Prolotherapy Workshop was Chaired by Jeffrey J.
Patterson, DO, Professor of Family Medicine at the University
of Wisconsin School of Medicine. He was assisted by Carl
Osborn, DO and Jean Paul Ouellette, MD. Prolotherapy
involves the injection of an irritant solution into the area
where ligaments have either been weakened or damaged
through injury or strain. The injection stimulates an inflam-
matory response that results in a tightening of aberrant
ligamental laxity and produces biomechanical stabilization of
the hyper-mobile region. The Prolotherapy Workshop con-
sisted of lectures describing the general history of prolo-
therapy and the specific techniques employed in the practice of
prolotherapy. Demonstrations of joint examinations and
prolotherapy injections were accomplished with the use of
patient models and video. This workshop allowed both the
physician new to prolotherapy and the experienced prolother-
apist to advance their skills and knowledge. Each of the two
days of the workshop concluded with a panel discussion that
reviewed case histories, prolotherapy ‘pearls’, and common
complications encountered in the practice of prolotherapy.
Dr Patterson commented, ‘It was exciting to work with ACAM
on this workshop. We found the people in the organization
to be stimulating and eager to explore prolotherapy as a
treatment for chronic [musculoskeletal] pain.’
Dileep S. Sachan, DVM, PhD, Professor in the Depart-
ment of Nutrition at the University of Tennessee and a board
member for the American College of Nutrition, chaired
ACAM’s Nutrition and Metabolism Review Workshop.
The workshop reviewed the fundamentals of physiology
and biochemistry as applied to the metabolism of various
macro- and micronutrients, including those involved with
a number of inborn errors of metabolism. Aspects of drug
metabolism, nutrient–drug interactions and food allergy
were also discussed. The pathophysiologies of acute and
chronic disease conditions were reviewed and nutritional
interventions in these conditions were addressed. The
workshop’s teaching faculty reviewed some of the nutritional
requirements inherent in conditions such as metabolic
syndrome, lipid dystrophies and disorders of the gastrointest-
inal tract, and the hepatobiliary, renal and cardiovascular
systems. They also reviewed nutritional requirements through
the life cycle as well as nutritional status assessment and
methods of feeding.
ACAM’s Hyperbaric Oxygen Therapy (HBOT) Workshop
was moderated by Joseph Rich, MD MPH, Director of the
Center for Environmental and Integrative Medicine in
Knoxville, Tennessee. HBOT is the periodic treatment of the
entire body with 100% oxygen at greater than normal
atmospheric pressures. The workshop convened a distin-
guished international group of physicians and scientists who
addressed the medical uses of HBOT in a diverse range of
disorders, including autism, cerebral palsy, stroke/brain injury,
non-healing wounds, osteomyelitis and Lyme disease. Dr Rich
commented, ‘Hyperbaric oxygen therapy is an underutilized
safe and effective therapy that has a surprisingly broad
spectrum of application for a wide number of medical
disorders. I urge progressive minded physicians to become
more familiar with HBOT and not to hesitate in employing it in
many acute and chronic diseases.’ The HBOT Workshop
allowed attendees to gain a broad understanding of the
principles and practical applications of HBOT in medicine.
Edwin Cooper, PhD, Distinguished Professor, Department
of Neuroimmunology, at the David Geffen School of Medicine
at University of California, Los Angeles, chaired ACAM’s
Writer’s Workshop. The workshop helped participants inter-
ested in developing their scientific writing skills to develop a
foundational perspective in the art and science of writing for
the peer-reviewed scientific literature. Several participants
brought their work for review and received constructive advice
on optimizing their presentations for submission to medical
journals.
Overall, conference attendees were very impressed with
the scientific and clinical evidence, which was presented in
support of CAIM therapies. Dr Bock commented ‘as the
incoming president of ACAM, it is a thrill for me to be a part of
such a positive event, and I greatly look forward to our next
meeting in Dallas, Infection and Chronic Illness: Integrative
Approaches to Lyme Disease, Stealth Infections and Inflam-
mation, which looks to be incredibly thought provoking and
very practical for any practitioners involved in the treatment
of chronic illness.
Anyone who missed the opportunity to attend ACAM’s
scientific conference ‘Scientific Integrative Medicine: Advan-
cing Health Horizons’ or the pre-conference workshops on
‘Scientific Writing’, ‘Prolotherapy’, ‘Hyperbaric Medicine’,
‘Nutrition and Metabolism’, and/or ‘Chelation and Heavy
Metal Toxicity’ can order DVDs/CDs from http://www.acam.
org or through telephone (800-532-3688 or 949-583-7666).
The American College for Advancement in Medicine
(ACAM) is a not-for-profit professional medical organization
for physicians interested in learning about evidence-based
CAIM therapies. ACAM’s goals are to improve skills,
knowledge and diagnostic procedures as they relate to
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and to develop awareness of alternative methods of medical
treatment. ACAM is dedicated to educating physicians and
other health care professionals on the latest findings and
emerging procedures in CAIM, botanical medicine, environ-
mental medicine and in the use of effective evidence-based
nutritional therapeutics. As the voice of CAIM, ACAM strives
to increase awareness and recognition of complementary,
alternative and integrative medical therapies, and play an
active role in shaping the future of the CAIM movement.
ACAM represents nearly 1000 physicians in 30 countries
and is the largest and oldest organization of its kind in the
world dedicated to providing its members with educational
excellence in integrative medicine. ACAM’s leading edge
educational programming facilitates the incorporation of
clinically relevant biomedical therapies by fast-tracking
scientific advancements in nutritional medicine, nutraceuti-
cals and ethnopharmacology into the practice of cutting edge
CAIM medicine.
ACAM was the first major medical organization to educate
its members about such now well-accepted concepts as
insulin resistance/metabolic syndrome, the detrimental effects
of homocysteine, the protective effects of antioxidants, the
clinical uses of essential fatty acids, cancer chemoprotection
therapies with diet and herbs, testing for cardiosensitive
C-reactive protein, the benefits of natural thyroid replace-
ment and nutritional medicine as applied to psychiatry.
ACAM’s next scientific conference ‘Infection and
Chronic Illness: Integrative Approaches to Lyme Disease,
Stealth Infections and Inflammation’ (approved for 17 AMA
ACCME hours) will be held at the Intercontinental Hotel in
Dallas Texas, from May 3–7, 2006. Pre-conference workshop
topics include 2-day trainings (approved for 15 AMA
ACCME’s) in ‘Metal Toxicology’, ‘Oriental Medicine’ and
‘Hyperbaric Oxygen Therapy’. ACAM will introduce two
exciting new 1-day workshops in Dallas, IV Therapies In
Clinical Practice’, and ‘Integrating CAIM into Clinical Prac-
tice’, which are both approved for 7.5 AMA ACCME credits.
For further information, please see http://acam.org/
DALLASabout.html or contact ACAM at þ1-800-532-3688
(in the USA) or þ1-949-583-7666 (outside the USA).
Summary of Presentations
David Brownstein, MD
Dr Brownstein is a Clinical Assistant Professor of Family
Medicine at Wayne State University and author of seven
books.
The Clinical Use of Iodine
Dr Brownstein reviewed the historyof iodine including aspects
about its discovery, the recommended daily allowances, and
its widespread deficiency in the modern diet. He highlighted
studies suggesting maternal imbalance of iodine may be
related to impaired psychoneurological development in their
children. He also noted that areas with the highest incidence
of goiter have higher rates of sudden infant death syndrome.
Dr Brownstein went on to discuss the physiology of iodine
and conditions successfully treated with iodine therapy. He
highlighted attention deficit disorder, fibrocystic breast
disease, thyroid disorders, ovarian cysts, peyronie’s disease,
infections, keloids and others. Dr Brownstein emphasized that
the breast is the second major storage compartment for iodine
just behind the thyroid and that diseased breast tissue, such as
that found in fibrocystic disease, will likely require more
iodine because of greater tissue depletion.
Mark Houston MD
Dr Houston is a Clinical Professor of Medicine at Vanderbilt
University School of Medicine and Chief of the Nutrition
Division at Saint Thomas Medical Group, Saint Thomas
Hospital in Nashville, Tennessee.
The Natural Treatment of Hypertension
Dr Houston reviewed the role of vascular biology in the
pathogenesis of hypertension. He discussed the environmental
and genetic interactions with micronutrients and their role in
modulating vascular inflammation in a manner that may result
in potentially less hypertension and end organ damage.
Dr Houston reviewed the wealth of scientific evidence that
confirms that oxidative stress, inflammation and immunologic
dysfunction initiate and propagate hypertension and cardi-
ovascular disease. He also summarized the mechanism of
action for the role of numerous nutrients, including amino
acids, minerals bioflavonoids and fatty acids, in reversing
hypertension.
Konrad Kail, ND
Dr Kail the co-founder of the Southwest College of Naturo-
pathic Medicine and Health Sciences and a recent advisor
to the National Center for Complementary and Alternative
Medicine at the NIH.
Managing Subclinical Hypothyroid
Dr Kail reviewed the risks associated with the syndrome
of Subclinical Hypothyroidism introducing a new manage-
ment paradigm that optimizes thyroid function based on
resting Metabolic Rate and Brachioradialis Reflexometry.
He reviewed factors affecting thyroid function including lead,
mercury, PCBs, fungicides and medications and highlighted
nutrients that help restore its function. Additionally, he
made the case for potentially significant declines in health
based on untreated subclinical hypothyroidism, including
increased cardiovascular, neurological and endocrinological
complications.
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Dr Levy was formerly an Assistant Professor of Medicine at
Tulane Medical School and is currently a Fellow of the
American College of Cardiology, and the author of four books.
Vitamin C: Past, Present and Future Applications
Dr Levy reviewed the strong role of Vitamin C in the
prevention of infection, treatment of scurvy and neutralization
of toxins. He made the very important point that all infections
and toxins will induce a localized and/or systemic Vitamin C
deficiency, which in its extreme form, may induce injury to
lipids. He reviewed the documented record of success of
Vitamin C in treating encephalitis, mononucleosis, diphtheria,
viral pneumonia, tetanus, mushroom poisoning, snakebites
and even barbiturate overdose. He reviewed vitamin C’s role
in dental disease and the unparalleled track record of safety of
this key nutrient.
Joseph C. Maroon, MD
Dr Maroon, the Vice Chairman of the Department of
Neurological Surgery at the University of Pittsburgh School
of Medicine and the team neurosurgeon for the Pittsburgh
Steelers.
Omega 3 EFA for Spine Pain
Dr Maroon reviewed the role of Omega 3 essential fatty acids
in the treatment of inflammation and highlighted the results of
his study using Omega 3 fatty acids in the treatment of 250
non-surgical neck or back pain patients. At the end of the
study, 60% of the participants stated their overall pain was
improved and 60% stated specifically that their joint pain had
improved. Overall, 80% stated they were satisfied with their
improvement and 88% stated they would continue to take
fish oils. Dr Maroon reviewed other botanical therapies for
inflammation including Green Tea, Turmeric, White Willow
Bark, Ginger and Boswellia. He also addressed the dosages of
Omega 3 oils necessary to control pain and he contrasted
the negligible side effects of Omega 3 oils with the well-
documented adverse drug reactions from over the counter and
prescription non-steroidal anti-inflammatory medications.
Amy Yasko, ND, PhD
Amy Yasko, ND, PhD, received her doctorate from Colgate
University in Microbiology, Immunology and Infectious
Disease and studied Naturopathy at Clayton College of Natural
Health.
Nutrigenomics, Methylation and RNA-Based Nutrients
Dr Yasko discussed the laboratory studies that allow for test-
ing for genetic susceptibility to disease and she extensively
discussed the science of nutrigenomics. ‘Nutrigenomics’ is
defined as the integration of concepts in molecular biology
and genomics in order to study the ability of foods and
nutritional supplements to interact with genes and to influence
our health and lower the genetic risk component for multi-
factorial disease. Dr Yasko described the methionine/folate
pathway as a central pathway that is especially amenable to
nutrigenomic screening. Defects in methylation can make one
more susceptible to diabetes, cardiovascular disease, thyroid
dysfunction, neurological inflammation, neurotransmitter
imbalances, atherosclerosis, cancer and autism. Dr Yasko
also described how defects in methylation can make one more
susceptible to the toxic effects of heavy metals, especially
arsenic and mercury. Dr Yasko described how heavy metals
can decrease the brain neurotransmitters, such as sero-
tonin and dopamine, if there are defects with BH4 and BH2
genes. By identifying the precise areas of genetic fragility,
it is possible to target appropriate nutritional supplements.
Dr Yasko discussed the potential uses of specific RNA-based
supplementation.
John Longhurst, MD, PhD
John Longhurst, MD, PhD, earned both his Medical Degree
and his PhD in Cardiovascular-Pulmonary Physiology from
the University of California at Davis. He is now Associate
Dean at UC Irvine and currently oversees the Susan Samueli
Center for Complementary and Alternative Medicine.
The Role of Acupuncture in Modern Healthcare,
Mechanistic Focus on the Cardiovascular System
Acupuncture is a 3000-year-old treatment and is known to be
useful in a number of chronic conditions such as pain,
depression, recurrent nausea and vomiting among other
conditions. Only recently has acupuncture been implicated
in the treatment of cardiovascular diseases. Dr Longhurst
described acupuncture’s usefulness in the treatment of
hypertension and chronic chest pain associated with myocar-
dial ischemia. He presented his laboratory’s research on the
cardiovascular influence of electroacupuncture (EA). His
laboratory has shown that EA at the Jianshi-Neiguan
acupuncture points stimulates the underlying median nerve to
provide sensory information through afferent nerve fibers to
the central nervous system, particularly to specific nuclei in
the hypothalamus and midbrain that are concerned with the
regulation of the sympathetic nervous system. Dr Longhurst
described how manual acupuncture and EA can also cause
similar sympathetic response to the cardiovascular system
and reduce blood pressure and ameliorate cardiac dysfunction
in an experimental model of demand induced myocardial
ischemia. It appears that one of the ways that acupuncture has
clinically significant effects is through a number of opioid and
opiod-like modulatory neuropeptides that reduce the activity
of neurons in the brain.
Leo Galland, MD
Leo Galland, MD author of ‘Super Immunity for Kids’ and
‘Power Healing’.
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Drug-Nutrient
Dr Galland explained that over half of all prescription
medication have the ability to deplete specific nutrients.
Dietary supplements can interact with medication affecting
absorption and toxicity of many drugs. Coenzyme Q10, folic
acid, magnesium, zinc, vitamins B2 and B6 are the nutrients
most commonly depleted. Mechanisms by which drugs
influence nutrients include the impairing of absorption or
bioactivation and through increasing excretion. Examples of
clinically significant nutrient depletions include statin and
Adriamycin depletion of Coenzyme Q10, Cisplatin depletion
of magnesium, Thiazides and 5-ASA derivatives depletion
of folate, and loop diuretics depletion of a wide range of
nutrients, including potassium, magnesium, calcium, certain
B-vitamins and Vitamin C. Dr Galland described some
beneficial drug–nutrient interactions such as the protective
effects on acetaminophen toxicity from the use of N-acetyl-
cysteine, L-methionine, SAMe, milk thistle and schisandra.
Protective supplements for aspirin and NSAID gastropathy (in
human trials) include Vitamin C, SAMe, deglycyrrhizinated
licorice and colostrum.
Stephen Sinatra, MD
Stephen Sinatra, MD is a Board Certified Cardiologist and
fellow of the American College of Cardiology and the
American College of Nutrition.
Metabolic Cardiology: A New Paradigm for
The Prevention and Treatment of Heart Disease
Dr Sinatra’s presentation introduced the concept of ‘metabolic
cardiology’ and highlighted the use of metabolic therapies in
heart disease. Metabolic therapy involves the administration of
a substance, that is normally found in the body, to enhance a
metabolic reaction within the cell. Dr Sinatra extensively
discussed the biology of Coenzyme Q 10, a lipid soluble
antioxidant that plays vital roles in cellular ATP processes and
thereby influences both systolic and diastolic function.
Dr Sinatra suggested that mitochondrial dysfunction may
result in symptoms of heart disease through some association
with Coenzyme Q 10 levels. As studies indicate that women
cannot make as much Coenzyme Q 10 as men and that women
with mitral valve prolapse and hypertension have more
diastolic dysfunction, since diastole requires more cellular
energy than systole and is more dependent on ATP, Dr Sinatra
hypothesized that women maybe more susceptible to diastolic
dysfunction due to lower Coenzyme Q10 and resultant lower
ATP. Dr Sinatra also discussed nutraceuticals that support
cardiac metabolism, such as D-Ribose and L-Carnitine.
D-Ribose is a naturally occurring pentose sugar that rebuilds
the energy stores in the cell. In the myocardium, the
rate-limiting step in the salvage and synthesis of ATP is
the availability of D-Ribose. These three compounds,
Coenzyme Q10, L-Carnitine and D- Ribose formed the triad
of Sinatra’s Metabolic Cardiology.
Randolph M Howes, PhD, MD
Randolph M Howes, PhD, MD completed residency in general
surgery and plastic surgery while doing basic research in
oxygen-free radicals at Johns Hopkins University. He invented
the triple lumen catheter and, in 2004, published the first
selective world review on oxygen metabolism in his book:
UTOPIA (Unified Theory of Oxygen Participation in Aero-
biosis).
Pro-oxidant Protection and Oxidative Self-Healing
Dr Howes discussed his research in free radical biology and
stated that his belief the free radical theory is unfounded and
that electronically modified oxygen derivatives (EMOD) are
of low toxicity and are essential for energy production,
pathogen protection, secondary messenger signaling and as
tumoricidal agents. His unified theory states that EMOD
deficiency levels allow for the manifestation of diseases,
including neoplasia, and is integral in the aging phenomena.
Dr Howes described how antioxidants become pro-oxidants.
He summarized his presentation by discussing how anti-
oxidants have failed to control aging and disease and he stated
that the scientific literature is increasingly showing that
antioxidants can harm biological systems.
Michael Uzick, ND
Dr Uzick received his doctorate of Naturopathic Medicine
from Bastyr University in Seattle Washington. He practices in
Tucson Arizona and lectures on alternative therapies for
cancer, hepatitis C and environmental toxicities.
Natural Strontium: A Highly-Effective Treatment for
Osteoporosis
Dr Uzick reviewed the fundamentals of osteoporosis and
introduced evidence that strontium can be a safe and an
effective adjunctive osteoporosis therapy. He pointed out that
conventional drug therapies using bisphosphonates are associ-
ated with esophageal complications, inflammatory conditions
and osteonecrosis of the jaw. Natural treatments that include
calcium and other minerals, vitamin D and vitamin K are both
safe and effective. Strontium is a non-toxic natural mineral that
was first reported in 1959 by the Mayo Clinic to be useful for
improving pain in severe osteoporosis. More recently, several
studies have documented the benefits of strontium for both
improving Dual Energy X-ray Absorptiometry (DEXA) scores
and in dramatically reducing fracture rates. When supplement-
ing with strontium and calculating bone mineral density
(BMD), DEXA scores must be adjusted to produce a
‘strontium-adjusted BMD’ due to strontium’s blockage of
X-rays. At 2 g of strontium per day, studies have shown as
much as a 49% decreases in fracture risk by one year, a 14%
increase in lumbar BMD and 12% decrease in C-telopeptide.
eCAM 2006;3(3) 389Bone biopsies from hundreds of animals and humans, who
have consumed strontium, show normal mineralization and no
cellular toxicity. Side effects were no greater than placebo in
most studies.
Jack Challem
Jack Challem is author of Feed Your Genes Right, The
Inflammation Syndrome, and Syndrome X. He writes and
publishes The Nutrition Reporter
TM newsletter. He has also
published original scientific articles in several journals, where
he has focused on the role of free radicals and antioxidants
in primate evolution.
Feed Your Genes Right: A Conceptual Framework for
Nutrient–Gene Interactions
Mr Challem described the biology of nutritional cofactors,
which affect gene structure and function, as well as the role of
genetic variations, which induce unique nutrient needs. Using
vitamin B-1 as an example, he pointed out that deficiency
in lab rats turns off 1000 genes and turns on 664 other genes.
Similar effects are likely for most nutritional deficiencies.
Mr Challem pointed out that the vast majority of people in our
population have many nutrient deficiencies. Mr Challem made
a case that the future of genetics research lies in the field of
‘Epigenetics’, which is the science devoted to the modifiers of
gene function and expression, rather than just looking at
effects of gene structure. He described how methylation often
silences genes while acetylation usually expresses them. Mr
Challem discussed how epigenetics can even be used to
explain multi-generational observations, since the effects of
nutrition and exercise have been observed to affect the health
of future generations.
Laura Power, PhD
Dr Power is a nutritional biochemist, with a Masters degree
in Nutritional Sciences from the University of Maryland and
a Doctorate in Holistic Clinical Nutrition from International
University. Her area of expertise is in the fields of immuno-
logy, allergy and epidemiology.
The 5 Biotypes Diets
Dr Power presented her 20 years of unique research correlating
blood types and ancestry to food allergies. Her research
identifies five diets based on ABO blood types (A1, A2, B, O
and AB), plus three subtypes based on being Rh-negative and
one’s gender. These blood types were correlated statistically
to four kinds of food allergies—IgE, IgG, Lectins and T-cell
mediated. She summarizes these results in her Diet
Compass
TM, a diagram that denotes the evolutionary origin
of the different dietary strategies.
Efrain Olszewer, MD
Dr Olszewer is the Director and Professor of the Brazilian
Foundation of Advanced Health Sciences, which teaches
postgraduate courses in medicine. He is the author of 38 books
and dozens of research articles.
EDTA, Calcium, Sodium and Suppositories as a
Therapeutic Approach for Chronic Degenerative
Vascular Diseases
Dr Olszewer discussed the administration of EDTA for
vascular disease and the effectiveness of different forms of
EDTA and different routes of administration. He began by
stating that, many years ago, his group in Brazil switched from
the ‘standard bottle’ of using 3 g of EDTA to the ‘1/2-bottle’ of
using 1.5 g of EDTA, because they found it just as effective in
prior studies. He presented data from a study of 12 patients
with stable angina where he compared the effectiveness of
IV Mg-NaEDTA with rapid IV CaEDTA and NaEDTA rectal
suppository. The IV treatments were administered once
weekly and the suppositories were five days per week. The
total weekly dose of EDTA was 1.5 g in each arm,
administered over 90 min for the MgNaEDTA, administered
over 15 minutes for the CaEDTA, and administered over
a period of five days for each of the 300 mg EDTA
suppositories. The study went for 12–15 months, and
IV patients received a total of 25 infusions. The outcomes
measured were chest pain on a stress test. Positive results were
observed in 87% of the MgNaEDTA patients, 69% of the
CaEDTA patients and 53% for those who used suppositories.
After 20 weeks, non-responders were moved from the
CAEDTA and suppository arms to the MgNaEDTA arm,
where they also reached an 87.5% positive response rate.
A second study looked at peripheral vascular disease in
24 patients, with positive improvements noted in 93% for the
MgNaEDTA group, 33% for CaEDTA group and 17% for
suppository group. Again, when non-responders were moved
to the MgNaEDTA arm, they achieved a positive response rate
of 83%.
A third study looking a strokes at less than 6 months, with
14 patients showed a similar pattern in clinical improvement
of 87.5% for MgNaEDTA, 66.6% for CaEDTA and 33.3% for
suppositories. 12.
Three patients were moved to the group receiving
MgNaEDTA and all three improved. A fourth study, analyzing
lead toxicity in the hair of 14 patients, showed positive
responses in all patients in all three arms. There was a slight
trend for patients in the CaEDTA arm to have rising
creatinine levels, which decreased after changing them to
the MgNaEDTA arm. Dr Olszewer’s concluded that
IV MgNaEDTA is the best approach for vascular disease,
and the IV CaEDTA is not as effective, but it can be used for
patients who will not sit still for the 90 min IVs. All three
approaches are powerful tools for lead detoxification. The
NaEDTA suppositories are effective only for lead intoxication,
not for vascular disease.
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Dr Miller is a 1989 graduate of Bastyr University. He is the
senior technical advisor for Thorne Research and is the senior
editor of Alternative Medicine Review, the MEDLINE-indexed
journal published by Thorne Research. He has authored over
20 scientific papers.
L-Arginine and its Effects On Endothelial Function and
Cardiovascular Health and Disease
Dr Miller reviewed endothelial function and pathophysiology
and then discussed the roles of nitric oxide (NO) and
L-arginine on blood vessel dilation. L-arginine is made
primarily in the kidneys from L-ornithine and L-citrulline,
with 3–5 g derived from dietary protein sources. Dr Miller
noted that many studies have shown improved endothelial
function after giving L-arginine. Nitric Oxide Synthase (NOS)
activity is inhibited by ADMA (asymmetric dimethylarginine),
which is increase in hyperlipidemia, hypertension, diabetes,
CHF and renal failure. Supplemental L-arginine can reverse the
detriments of ADMA by restoring endothelial NOS activity. L-
arginine has been shown to improve the vascular dilation effect
of statin drugs, improve exercise duration in CHF, reduce
homocysteine, lower blood pressure and increase cardiac
perfusion by 22%. Dr Miller noted that L-arginine works in
complement with nutraceuticals such as B-vitamins, fish oil,
red rice yeast extract and CoQ-10.
The authors wish to thank Michael Janson MD for his
proofreading and editing of this article.
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